Recent Abacavir Use and Incident Cardiovascular
Disease in Contemporary Treated PLWH within the RESPOND Cohort Consortium
18th EACS 2021 Oct 27-30 virtual & London, UK
Nadine Josephine Jaschinski on behalf of the RESPOND study group
CHIP, Section 2100, Rigshospitalet, Copenhagen, Denmark
Co-authors: L. Greenberg; B. Neesgaard; J. M. Miró; K. Grabmeier-Pfistershammer; G. Wandeler; C. Smith; S. De Wit; F. Wit; A. Pelchen-Matthews; C. Mussini; A. Castagna; C. Pradier; A. d'Arminio Monforte; J. J. Vehreschild; A. Sönnerborg; A. Volny-Anne; A. Carr; L. Bansi-Matharu; J. D. Lundgren; H. Garges; F. Rogatto; R. Zangerle; H.F. Günthard; L. D. Rasmussen; C. Necsoi; M. van der Valk; M. Menozzi; C. Muccini; A. Mocroft; L. Peters and L. Ryom
